FDA approves REBLOZYL for treating anaemia in adults with beta thalassemia
The BELIEVE trial has reached both primary and secondary end points and REBLOZYL has demonstrated reduced RBC transfusion…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Nov 19
The BELIEVE trial has reached both primary and secondary end points and REBLOZYL has demonstrated reduced RBC transfusion…
21 Oct 19
The previous phase 2 study of MOB-015 showed the delivery of high microgram levels of terbinafine into the…
21 Oct 19
FDA approval of ULTOMIRIS based on data from two global, single-arm open-label studies of ULTOMIRIS, separately in adults…
Trinity College scientists claim to have identified a protein linked to lower blood sugar levels that may help…
18 Sep 19
The US Food and Drug Administration (FDA) has approved Mylan’s Abbreviated New Drug Application (ANDA) for the product
06 Sep 19
SunGen has opened its injectable division through the acquisition of a New Jersey-based pharmaceutical company
18 Jul 19
A powerful bee sting vaccine designed to eliminate the risk of a severe allergic reaction to European honeybee…
25 Jun 19
Chronic diseases, such as hypertension and rheumatoid arthritis are persistent conditions, which require lifelong management
20 Apr 19
Over half of patients who are prescribed statins do not see their cholesterol drop to desired levels within…
01 Feb 19
The Association of the British Pharmaceutical Industry (ABPI) has warned that the UK is in danger of losing…